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Abstract: Cerebral blood ﬂow (CBF) during stepped hypercapnia was
measured simultaneously in the rat brain using near-infrared diffuse corre-
lation spectroscopy (DCS) and arterial spin labeling MRI (ASL). DCS and
ASL CBF values agree very well, with high correlation (R=0.86, p< 10−9),
even when physiological instability perturbed the vascular response. A
partial volume effect was evident in the smaller magnitude of the optical
CBF response compared to the MRI values (averaged over the cortical
area), primarily due to the inclusion of white matter in the optically sampled
volume. The 8.2 and 11.7 mm mid-separation channels of the multi-distance
optical probe had the lowest partial volume impact, reﬂecting ∼75 % of
the MR signal change. Using a multiplicative correction factor, the ASL
CBF could be predicted with no more than 10% relative error, affording
an opportunity for real-time relative cerebral metabolism monitoring in
conjunction with MR measurement of cerebral blood volume using super
paramagnetic contrast agents.
© 2010 Optical Society of America
OCIS codes: (170.2655) Functional monitoring and imaging; (170.1470) Blood or tissue con-
stituent monitoring; (170.0170) Medical optics and biotechnology; (170.3340) Laser Doppler
velocimetry.
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1. Introduction
The cerebral metabolic rate of oxygen consumption (CMRO2) is a physiological parameter
closely linked to neural activation [1,2], as well as to various disease states [3–6]. A key ele-
ment necessary for CMRO2 monitoring is a measure of cerebral blood ﬂow (CBF). While bolus
injection methods, using tracers such as radioactive [7] and ﬂuorescent [8,9] microspheres have
proven quantitative accuracy, they only measure CBF at a few discrete timepoints. In addition
to these steady state CBF measurements, accurate assessment of dynamic CBF changes with
good temporal resolution provides a way to further understand neurohemodynamic coupling
and metabolic parameters. Currently, continuous CBF monitoring can be achieved using Laser
Doppler ﬂowmetry (LDF) [10,11], Transcranial Doppler Ultrasound (TCD) [12] or MRI-based
Arterial Spin Labeling (ASL) [13,14]. However, TCD can only give blood ﬂow in large vessels,
while LDF is an invasive technique requiring opening of the scalp and skull for probe place-
ment. On the other hand, ASL provides an effective method for mapping CBF; however, the
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Diffuse correlation spectroscopy (DCS) [15–17], also known as Diffusing Wave Spec-
troscopy (DWS) [18] is a novel method for non-invasive CBF measurement at depth with ex-
cellent temporal resolution and sensitivity, especially effective in rodents, piglets and neonates.
DCS cerebral blood ﬂow measurements have been validated against LDF [19,20], ﬂuorescent
microspheres [21], Xenon-CT [22], TCD [23,24] and MRI-ASL [25,26]. Outside the brain,
DCS has also been validated against MRI-ASL for calf-muscle blood ﬂow [27]. These encour-
aging results suggest DCS could be used for continuous non-invasive CBF estimation, and may
be integrated with functional MRI methods for brain measurements.
In this work, we validate DCS against ASL measurements of CBF in the rat-brain using a
graded hypercapnic challenge. We show strong linear correlation between DCS and ASL mea-
sures of blood ﬂow and demonstrate DCS can be used together with a partial volume correction
factor to recover the ASL data. We discuss the sources of the partial volume effect and suggest
ways to minimize its size. Thus, we provide further proof of the feasibility of using DCS in
conjunction with functional MRI in the brain.
2. Materials and Methods
2.1. Animal Preparation and Measurement Protocol
We used a total of seven adult male Sprague Dawley rats (Charles River, MA, USA; weight
between 250 and 350 grams). Both left and right femoral veins (for infusion of anesthetics and
contrast agent administration, respectively) and right femoral artery (for blood pressure moni-
toring and blood gas analysis) were catheterized. Animals were initially anesthetized with 2.0%
isoﬂurane in 100% O2, then tracheotomized and mechanically ventilated with 1.5% isoﬂurane
in 70% N2O/30% O2 for the duration of surgery. Body temperature was measured with a rec-
tal probe. Before the optical/MRI experiment, the anesthetic regimen was switched from the
halothane gas mixture used for surgery to continuous infusion of α-chloralose (30 mg/kg/h),
preceded by a loading bolus (∼20 mg/kg). Concurrently with α-chloralose administration, rats
were paralyzed with an intravenous bolus of pancuronium (1 mg/kg), which was followed by
continuous infusion (∼ 1.25 mg/kg/h) of pancuronium. Body temperature, blood oxygen satu-
ration level, heart rate and blood pressure were monitored and carefully maintained at normal
levels throughout the experiment. A temperature-controlled water blanket was placed under the
rat’s torso to maintain body temperature at 37.0 ◦C. A sufﬁcient time was allowed for the anes-
thetic transition before the optical/MRI measurements. Blood gases (pO2 and pCO2) as well
as pH were veriﬁed to be within normal ranges before the animal was inserted in the scanner
cavity. Blood gas monitoring did not continue during the scans due to concerns over the need to
use a lengthy (>1.5m) arterial sampling line as well as a lack of manpower to take and process
samples while operating the optical and MR equipment. An additional two rats were later used
as a control set using the same animal preparation procedure up through and including placing
the rat in the scanner bore. However, we did not run the scanner or the optical measurement,
thus being able to access the rat inside the scanner cage and allowing for a short (0.3 m) arterial
line. Average blood gas values from these animals were used to estimate CO2 reactivity in the
main group under the assumption of similar behavior between the two sets.
The animals were mechanically ventilated at all times. The hypercapnic challenge involved
exposure to a premixed gas consisting of 2.5, 5 or 7.5% CO2 and 92.5, 95, 97.5% air, respec-
tively. Each trial involved a 5 minutes baseline (100% air), 15 minutes stepped hypercapnia (5
minutes each at 2.5, 5, and 7.5% CO2, respectively), followed by a 5 minute return to baseline.
Each trial was repeated twice for each animal. Optical and MR acquisitions were continuously
performed during the entire length of both trials.
#129409 - $15.00 USD Received 2 Jun 2010; revised 24 Jul 2010; accepted 24 Jul 2010; published 10 Aug 2010
(C) 2010 OSA 1 September 2010 / Vol. 1,  No. 2 / BIOMEDICAL OPTICS EXPRESS  5562.2. Near Infrared Cerebral Blood Flow Measurement
We constructed a diffuse correlation spectrometer (DCS) system similar to the one developed
by the Yodh group at Univ. of Pennsylvania [25]. A solid-state long coherence length laser at
785 nm (CrystaLaser RCL-785-080-S) was coupled to a 62.5μm multi-mode gradient index
ﬁber and delivered to the tissue. The diffusely reﬂected light was collected by four single-
mode optical ﬁbers and detected by four photon-counting avalanche photodiodes (PC-APD,
Perkin Elmer SPCM-AQR-14-FC). The intensity auto correlation function of each channel was
computed by a digital correlator (Correlator.com Flex32-8ch) over a delay time range of 200 ns
- 0.5 s. A correlation curve was acquired approx. 1.5 times per second. To improve the accuracy
of the blood ﬂow estimation the optical properties of the tissue were measured at the same time
using a frequency domain near infrared spectrometer (FD-NIRS ) [28, 29] using one source
and four detector ﬁber bundles co-located with the DCS ﬁbers, as described in section §2.4.
The multi-distance FD-NIRS measurement was used to quantify the scattering and absorption
coefﬁcients by ﬁtting said measurements to the standard diffusion approximation model for
light transport in a semi-inﬁnite turbid medium. The instruments operated in a time-interleaved
fashion, where in each 15 second time interval, DCS data was acquired for 9 seconds at 1.5 Hz,
followed by FD-NIRS data acquired for 6 seconds at 12.5 Hz.
2.3. Arterial Spin Labeling MRI
MRI measurements were performed using a horizontal bore 9.4 T Bruker/Magnex system,
equipped with a home-built rat head surface RF transmitter and receiver coil, approximately
30 mm in diameter. A surface coil was used for brain imaging and a neck coil for perfusion
labeling. Coil-to-coil electromagnetic interaction was actively decoupled. Simultaneous BOLD
and CBF measurements were made using the two-coil continuous arterial spin-labeling method
with single-shot, GE (TR/TE=3700/13 ms) echo planar imaging (EPI) acquisition (three 1 mm
slices with inter-slice separation of 1 mm, FOV=2.3x2.3 cm2, 64x64 matrix). Paired images
were acquired alternately with and without arterial spin labeling.
2.4. Hybrid Instrumentation and Combined Optical-MRI Probe
A combined optical probe/MR coil assembly was fabricated to ﬁt in the animal holder tube
of the Bruker MRI system (Fig. 1). A plastic stereotactic frame held the animal’s head ﬁxed
during the experiment. Both optical systems delivered and collected light through co-located
source and detector ﬁbers at 5.3, 8.2, 11.7 and 15.5 mm source-detector separations. The optical
probe made of thermoplastic material is rigidly attached with two screws to the MR coil, thus
giving reliable positioning of the optical ﬁbers in the MR ﬁeld of view. The acquisition start
time was recorded to the second for all three instruments (DCS, FD-NIRS, MRI) as well as the
gas change timing. It is expected that an approximately 30 second delay occurs before the gas
change reaches the animal due to the length of the breathing gas lines.
2.5. Data Analysis
Four animals were used in the data analysis. Data from the other three could not be used be-
cause of hardware problems that resulted in poor labeling coil performance and subsequent low
quality ASL images.
2.5.1. DCS data processing
The diffusion correlation equation offers the theoretical framework for analyzing the DCS data.
As detailed by Boas et al. [15, 16] and further validated by Cheung et al., Culver et al. and
Durduran et al. [19,20,25], the normalized intensity temporal auto-correlation function, g2(τ)
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Fig. 1. Multi-modality probe design. a) Photograph of MRI head coil and optical probe
assembly on a rat, ready to be inserted into the scanner bore; a separate ASL labeling coil
is placed under the neck area. b) Schematic of optical probe, with ﬁbers connected to both
the FD-NIRS and the DCS system inserted at each location. Source position is shown in
red, while detector positions are in blue, with source-detector separations of 5.3, 8.2, 11.7,
and 15.5 mm, respectively
is given by:
g2(rs,rd,τ)=1+β

exp

−

3μ 
sμa+PRBCμ 2
s k2
0 < Δr2(τ) >
1/2
| rs−rd |
2
(1)
where β is the coherence factor, rs and rd are the source and detector positions, respectively, τ
is the correlation time, μ 
s is the reduced scattering coefﬁcient, μa is the absorption coefﬁcient,
k0 is the wavenumber for the laser light, PRBC is the probability of scattering from a moving
scatterer (most likely a red blood cell), and < Δr2(τ) > is the mean square displacement of the
moving scattering particles. Several studies [19,25] have shown that DCS correlation proﬁles
from living tissues can be ﬁt well by assuming particle displacement follows Brownian motion
dynamics:
< Δr2(τ) >= 6Dbτ (2)
where Db is the Brownian diffusion coefﬁcient. Since PRBC is generally unknown, it is grouped
together with Db to form a blood ﬂow index as CBFDCS = DbPRBC. To obtain the time-course
of CBFDCS we ﬁrst recover the absorption and scattering optical properties from the FD-NIRS
instrument. These are then interpolated across the DCS timepoints and used in ﬁtting Eqs. (1),
(2) to the experimental measurements for each DCS source-detector pair individually.
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CBF maps have been created by subtracting tagged images from their untagged counterparts for
each slice, resulting in a frame rate of one image every 7.4 seconds. Regions of interest were
deﬁned in the cortex in an area 2 mm wide under the location of the optical ﬁbers. Because
baseline blood ﬂow was close to the system noise level, temporal traces were normalized to the
average of the second half of the ﬁrst 2.5% CO2 period.
2.5.3. Comparison and correlation
The level of correlation of normalized time courses obtained from the two modalities was quan-
tiﬁed using the Pearson product-moment correlation coefﬁcient. Further, we calibrated the op-
tical partial volume effect size over the entire measurement set, and estimated the accuracy in
recovering ASL CBF measures from the DCS data.
3. Results
3.1. CBF response during stepped hypercapnia
Fig. 2. ASL slice showing optical ﬁber locations (blue) and region-of-interest for averaging
of MRI CBF (magenta)
Figure 2 shows a time-average of the middle ASL slice in one of the animals. The region of
interest (ROI) used to obtain the MRI data is shown as a magenta rectangular overlay, while
the location of the line of optical ﬁbers is indicated using a blue ﬁlled rectangle above the MRI
ROI. Figure 3 displays the average CO2 response from N=4 stepped hypercapnia periods col-
lected from multiple rats. Both MRI-ASL and DCS are included, and separate time-courses
are plotted for each of the DCS channels (error bars represent standard errors). Values plotted
are normalized to the average of the 2nd half of the 2.5% CO2 hypercapnia period, since the
MRI-ASL data of that segment had the lowest standard deviation. A progressive increase in
cerebral blood ﬂow is noted for both measurement methods, as expected. The DCS CBF in-
crease is lower compared to the ASL CBF, with the smallest increase displayed by the most
superﬁcially sensitive channel and very similar time-courses observed for the other three larger
separation channels, with a small decrease at the largest separation. A summary of the observed
relative CBF values is given in Table 1 (data averaged over the 2nd half of each CO2 level). The
variations in optical absorption and scattering are much smaller than the increase in blood ﬂow.
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Fig. 3. Average normalized CBF time course for N=4 hypercapnia periods, from both ASL
(black) and the 4 optical channels with 5.3 (blue), 8.2 (red), 11.7 (green) and 15.5 (ma-
genta) mm separations, respectively; vertical bars indicate gas changes from 0→2.5 %
CO2, 2.5→5% CO2,5 →7.5% CO2 and 7.5→0% CO2
The average changes with respect to the 0% CO2 baseline at λ=785 nm are −0.76±0.07%,
0.63±0.64% and 2.41±1.16%, respectively for μa, and 1.23±0.07%, 2.41±0.14% and
3.40±0.16%, respectively for μ 
s at 2.5%, 5% and 7.5% inspired CO2 volume fraction.
Table 1. Average relative CBF during stepped hypercapnia. Averages taken over the second
half of each hypercania period. Baseline value for MRI-ASL is italicized to indicate lower
conﬁdence because of the lower SNR of the corresponding raw data.
CO2 level
0% 2.5% 5% 7.5%
DCS Ch.1 (5.3 mm) 72% 100% 118% 133%
DCS Ch.2 (8.2 mm) 71% 100% 124% 154%
DCS Ch.3 (11.7 mm) 75% 100% 124% 155%
DCS Ch.4 (15.5 mm) 78% 100% 122% 150%
MRI-ASL 68% 100% 150% 224%
While blood gases were not available for the animals reported in Table 1, the average pCO2
values in the two animal control set were 38.2±4.2 mmHg, 43.2±4.7 mmHg, 54±6.3 mmHg,
and 68.5±6.3 mmHg (mean ± stdev) for baseline, 2.5%, 5% and 7.5% CO2 respectively (av-
erage of 3 stepped hypercapnia trials on each rat). Making the assumption that these animals
behaved similarly to the ones used as the main group, the CO2 reactivity appears to be 3.74% /
mmHg pCO2 from the DCS data (average of ch.2 and 3) and 4.91% /mmHg pCO2 for the ASL
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3.2. Correlation of rCBFDCS and rCBFASL
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Fig. 4. DCS-ASL correlation scatter plot.
Figure 4 shows a scatter plot of relative CBF values measured with MRI-ASL and DCS dur-
ing a representative stepped hypercapnia experiment, using the same normalization reference
as the previous section. The DCS data represents an average of the two mid-separation DCS
channels, which show the highest relative amount of response to hypercapnia. There is good
linear agreement between the two methods, with a correlation coefﬁcient R=0.86, and proba-
bility of no-correlation p< 10−9. Table 2 summarizes the ratios between the fractional rCBF
changes measured with DCS versus those measured with MRI-ASL. These ratios are calculated
between 2.5% and 5% CO2 and between 2.5% and 7.5% CO2 levels, respectively and averaged
over the same 4 stepped hypercapnia experiments used to generate Fig. 3. Note that, as shown
in Table 2, DCS appears to always underestimate the ASL CBF change, more so at higher CBF
values. The two mid-separation DCS channels (with inter-ﬁber distances of 8.2 and 11.7 mm
respectively) reﬂect the ASL measurement best, with an average correction coefﬁcient of 1.33
(i.e. rCBFASL/ rCBFDCS =1.33). Finally, Table 3 gives the relative error encountered when
using the the above correction coefﬁcient to predict the ASL measured ﬂow change from the
mid-separation DCS data. Note that over the range of cerebral blood ﬂows resulting from 2.5%
to 7.5% hypercapnia, calibrated DCS measurements can predict MRI ASL rCBF values with
no more than ±10% relative error.
Table 2. Percent of MRI relative CBF change reﬂected by the DCS relative CBF change.
Values less than 100% denote rCBFDCS underestimates rCBFASL
CO2 level DCS Ch.1 DCS Ch.2 DCS Ch.3 DCS Ch.4
5% +79% +83% +83% +81%
7.5% +59% +69% +69% +67%
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CO2 period)
CO2 level
2.5% 5% 7.5%
Prediction Rel. Err. Prediction Rel. Err. Prediction Rel. Err.
DCS Ch.2 100% N/A 165% 9.93% 205% -8.58%
DCS Ch.3 100% N/A 165% 9.93% 206% -7.98%
MRI-ASL 100% N/A 150% N/A 224% N/A
3.3. Inﬂuence of physiological instability
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Fig. 5. CBF measurement during physiological instability. a) CBF time course from DCS
(blue) and ASL (red) data; b) ASL vs DCS correlation plot
Figure 5 shows the relative CBF traces from ASL and the average of the mid-separation DCS
channels (Ch. 2 and Ch. 3) during a stepped hypercapnia experiment affected by physiological
instability. Speciﬁcally, the rat experienced a cortical spreading depression (CSD) wave evident
in the full-frame time-resolved blood ﬂow MR images (not shown). The temporal features of
the two methods remain well aligned, while the scatter plot again indicates strong correlation,
despite the CSD episode.
4. Discussion
Cerebral blood ﬂow measurements are an essential component of cerebral oxygen metabolism
monitoring. Diffuse correlation spectroscopy is the ﬁrst optical method with the ability to quan-
tify blood ﬂow in thick tissue without the need for a contrast agent. Substantial effort has been
expended to validate DCS [19–27] including previous validation against MRI ASL for calf
muscle blood ﬂow [27], cortical motor activation [25] and cerebral blood ﬂow in neonates [26].
This study further validates DCS against ASL in the multi-layered environment of the intact
rat brain. The DCS optical measure of blood ﬂow, represented by the product DbPRBC exhibits
good linear correlation with ASL data averaged over the ﬁeld of view of the optical probe.
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link between the optical and MR ﬂow measures at a fundamental level, as expected. While the
linear relationship between rCBFDCS and rCBFASL allows a simple multiplicative correction
factor to be used to recover ASL variation values from DCS data, with good results as shown
above, the signiﬁcant underestimation of ASL CBF by DCS warrants further analysis.
There are two main possible sources of discrepancy – partial volume effects contaminating
the cortical DCS signal and differences in the nature of the ﬂow measurement between DCS
and ASL. While analysis driven by segmented MRI structural images is beyond the scope of the
current article, to further understand the magnitute of potential partial volume effects we might
have encountered, we performed a set of Monte Carlo simulations on a ﬂat layered geometry
that mimicked the rat head. We used morphological data from the Paxinos and Watson rat brain
atlas [30], the same probe ﬁber locations used for the hypercapnia experiments, a standard set of
brain optical properties [31], and estimates of brownian diffusion coefﬁcient for scalp and cor-
tex from Li et al. [18]. Further we assumed that cortical blood ﬂow doubles due to hypercapnic
stimulation, while white matter has half of both the baseline perfusion and the CO2 reactivity
of the gray matter [32–34]. We employed the Monte Carlo code developed by Boas et al. [35]
due to its ability to handle heterogeneous optical properties with a modiﬁcation to additionally
report momentum transfer accumulation along a photon path [36,37]. The simulated correlation
decay proﬁles were then ﬁtted using the same approach outlined in §2.5.1. From these simula-
tions we found that all optical detectors collect photons that have sampled a signiﬁcant amount
of white matter with the proportion of white matter pathlength varying between 40% (Ch.1) to
70% (Ch.4). Further, scalp and skull account for 10-20% of the photon pathlenghts, leading to
a 2% (Ch. 4) to 7% (Ch. 1) underestimation of cerebral blood ﬂow. Finally, the only way to
explain a signiﬁcantly lower ﬂow variation in the shortest source-detector separation as seen in
our experimental data is to assume an air gap between the probe and the scalp of the rat. Such
a 1-2 mm air gap likely occured due to the weight of the optical ﬁbers bending the probe as the
rat tube was inserted into the MR bore. Aside from the probable presence of the air gap, the
main conclusions from the Monte Carlo simulations are that the most signiﬁcant partial volume
effect is due to the inclusion of a substantial amount of white matter in the photon migration
path, while the skin and skull partial volume effect, even though present, has a minor impact.
The inﬂuence of lower white matter baseline blood ﬂow and CO2 reactivity helps explain three
important features of our results: a lower CBF increase seen by DCS compared to the cortically
averaged MR ASL blood ﬂow, a slightly reduced CBF response to CO2 observed at the largest
source-detector separation (Ch. 4) which is affected by the largest white matter partial volume
effect, and the increasing discrepancy vs. ASL at 7.5% CO2 compared to the 5% CO2 level that
likely results from the further increased perfusion contrast between the cortex and white matter
at high inspired CO2 concentration. The reduced CBF reponse at larger ﬁber separations has
also been observed in the rat brain by Cheung et al. [19] for a 9 mm source-detector separation.
Many of these caveats are related to the probe design and can be alleviated for future rat experi-
ments by improving the rigidity of the probe and by reducing source detector separations. Note
that we chose a fairly large probe ﬁber spacing to be able to maintain the accuracy of the diffu-
sion approximation model used for FD-NIRS data analysis. However, Monte Carlo simulations
and/or ﬁnite element methods could be used to relax this requirement and maintain accurate
optical property recovery at short source detector distances.
Although the ability to explain many features of our results by using Monte Carlo simula-
tions in a layered geometry is encouraging, these simulations predict at most a 15% reduction
in measured DCS CBF vs. actual cortical blood ﬂow for our probe ﬁber spacing in a typical
rat, less than the 25% underestimation observed vs ASL-MRI. Further, the overall 0-7.5% CO2
transition was accompanied by an average DCS CBF increase to 212% of the baseline, higher
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dioxide level (8%), and the estimated 3.74% per mmHg pCO2 reactivity is at the upper end of
literature values which range between 2% and 4% per mmHg pCO2 [39–41] (with the caveat
that it was calculated using two different sets of animals). Finally, whereas Kim et al. [22] val-
idated DCS CBF measurements against Xenon CT in an adult population noting only a 10%
proportionality mismatch, Durduran et al. [26] presented DCS CBF validation data against MRI
ASL in a neonatal population where the MRI ASL relative changes were 1.3 times bigger than
the DCS relative CBF increase (as shown in Fig. 5 of the cited reference). Considering the to-
tality of these observations – on one hand signiﬁcant underestimation of ASL CBF measures
by DCS, and the good agreement of DCS CBF with Xenon CT as well as literature CO2 reac-
tivity on the other hand – suggests there are perhaps structural differences in the way DCS and
MRI-ASL measure tissue perfusion, related to their different mechanisms of sensitivity to ﬂow.
For example the ASL data may be affected by a perfusion related reduction in transit time, as
well as hypercapnia induced blood oxygenation changes that modify local T2* and thus image
intensity [42]. Another potential source of error in the DCS CBF estimate relates to the way
contributions from blood volume and blood ﬂow velocity are reﬂected in the PRBCDb quantity
used as a blood ﬂow index. CBF changes are the product of vessel cross-sectional area changes
(linearly related to PRBC under the assumption of constant length of the vessel network) and
ﬂow velocity changes (reﬂected by Db). Since Db is representative of root mean square dis-
placement of scatterers in the blood, and not of their linear movement, it can be argued that the
PRBCDb product underestimates the impact of blood volume changes by a factor of
√
PRBC, thus
further explaining the underestimation of ASL CBF by the DCS method.
Combined DCS and FD-NIRS measurements can be used to estimate changes in cerebral
metabolism using Fick’s law, which is often expressed as rCMRO2=rOEF.rCBF, where OEF is
the oxygen extraction fraction, equal to the difference between the blood oxygen saturation on
the arterial vs. venous side of a tissue region, and the preﬁx ’r’ stands for relative change. The
use of a compartmental model that assumes the measured tissue hemoglobin oxygen saturation
is a mixture of arterial, capillary and venous blood [19,43] in conjunction with DCS and NIRS
data not corrected for partial volume effects has been met with success in several studies where
CMRO2 changes occur on a larger spatial scale, such as hypercapnia [19,26], ischemia [20],
or early brain development [23]. On the other hand, where metabolic changes are highly local-
ized, such as during cerebral functional activation partial volume correction of the optical data
appears necessary to obtain accurate CMRO2 data [25].
The goal of the current publication is to suggest that DCS calibration against MRI-ASL can
enable multi-modal MRI-optical continuous CMRO2 monitoring during brain functional ex-
periments, with potential improved relative metabolism quantiﬁcation accuracy compared to
current methods. The ability of the ASL technique to obtain fairly detailed perfusion images
permits the calibration of the DCS ﬂow measurement for a speciﬁc tissue volume that matches
the area where functional activation occurs. Speciﬁcally, a stepped hypercapnia challenge can
be performed at the beginning of the experimental protocol, leading to a set of correction coefﬁ-
cients that can convert DCS measurements into corresponding ASL blood ﬂow changes for any
particular cerebral region of interest. Then, the standard protocol for MR imaging of CMRO2
can be followed, usually requiring the injection of a contrast agent for the determination of
the cerebral blood volume. The DCS data can then be directly substituted for relative ﬂow in
the rCMRO2 calculation, instead of using an assumed blood-volume blood-ﬂow relationship
such as the Grubb power law [44], which may result in signiﬁcant errors in the assumed ﬂow
changes [45,46]. A further advantage of using DCS for CBF quantiﬁcation is the high tempo-
ral resolution of the optical methods, combined with good SNR for measurements at baseline
ﬂow rates. This is due to the fact that auto-correlation decay due to baseline ﬂow is still much
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measurements taken post mortem show a correlation decay 3-4 orders of magnitude slower than
before the animal is sacriﬁced).
5. Conclusion
We have demonstrated a strong linear relationship between diffuse correlation spectroscopy
and MRI arterial spin labeling estimates of cerebral blood ﬂow in the rat brain. While DCS
measures underestimate the ASL changes, a multiplicative correction factor can be used to
predict MRI ﬂow changes from the DCS data. We propose that using stepped hypercapnia for
DCS-ASL ﬂow calibration can be used to enable multi-modal optical-MRI cerebral metabolism
monitoring with improved accuracy vs. current methodology due to simultaneous blood ﬂow
and blood volume quantiﬁcation as well as improved ﬂow measurement noise, especially near
baseline values.
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